Stevens L M, Anderson J P, Lee S K. "一种的合成方法" [P]. US Patent, US 9101180 B2, 2021-06-28.
Anderson J P, Davis P L, Thompson G K. "Method for the Synthesis of Methyl 2-[3-(trifluoromethyl)-1h,4h,5h,6h-cyclopenta[c]pyrazol-1-yl]acetate" [P]. US Patent, US 11655353 B2, 2020-12-20.
发明人李文辉,郭海燕,沈红梅. "A Process for Preparing High-Purity Methyl 2-[3-(trifluoromethyl)-1h,4h,5h,6h-cyclopenta[c]pyrazol-1-yl]acetate" [P]. 中国发明专利, 专利号 CN 112764370 A, 授权公告日 2015-02-28.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2018, 2434, (8), 5593-5606.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2023, 2407, (9), 2489-2502.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 2-[3-(trifluoromethyl)-1h,4h,5h,6h-cyclopenta[c]pyrazol-1-yl]acetate Using HRMS and NMR". Biomed. Chromatogr., 2017, 2021, (12), 9368-9371.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2015, 572, (2), 2650-2669.